The RAASi Debate – Will the future be clearer?

Topic: Heart failure, other
Sponsored by ZS Pharma, Inc.

About the speaker

Doctor Peter McCullough

0 follower

6 more presentations in this session

The RAASi Debate – Welcome and Introductions.

Speaker: Doctor P. McCullough Professor C. Ronco (Padua, IT)

Thumbnail

The RAASi Debate – Team #1 Arguments: RAASI should continue in HF and CKD patients.

Speaker: Professor I. Pina (Philadelphia, US) Professor F. Locatelli (Lecco, IT)

Thumbnail

The RAASi Debate – Team #2 Arguments: RAASI should be stopped in HF and CKD patients.

Speaker: Professor S. Anker (Berlin, DE) Professor B. Palmer

Thumbnail

The RAASi Debate – Team #1 challenges team #2

Speaker: Professor I. Pina (Philadelphia, US) Professor F. Locatelli (Lecco, IT)

Thumbnail

The RAASi Debate – Team #2 challenges team #1

Speaker: Professor S. Anker (Berlin, DE) Professor B. Palmer

Thumbnail

Access the full session

The RAASi debate: should RAAS blockade continue with a declining eGFR?

Speakers: Doctor P. McCullough, Doctor P. McCullough, Professor C. Ronco, Professor I. Pina, Professor F. Locatelli...
Thumbnail

About the event

Image

ESC CONGRESS 2014

30 August - 3 September 2014

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb